Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1976 1
1998 1
2003 1
2005 2
2006 1
2008 1
2014 1
2015 1
2016 3
2018 2
2020 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Post-Ebola Symptoms 7 Years After Infection: The Natural History of Long Ebola.
Wohl DA, Fischer WA, Mei W, Zou F, Tozay S, Reeves E, Pewu K, Demarco J, Schieffelin J, Johnson H, Conneh T, Williams G, McMillian D, Brown J. Wohl DA, et al. Among authors: mcmillian d. Clin Infect Dis. 2023 Feb 8;76(3):e835-e840. doi: 10.1093/cid/ciac732. Clin Infect Dis. 2023. PMID: 36065768 Free PMC article.
Stigma and Ebola survivorship in Liberia: Results from a longitudinal cohort study.
Overholt L, Wohl DA, Fischer WA 2nd, Westreich D, Tozay S, Reeves E, Pewu K, Adjasso D, Hoover D, Merenbloom C, Johnson H, Williams G, Conneh T, Diggs J, Buller A, McMillian D, Hawks D, Dube K, Brown J. Overholt L, et al. Among authors: mcmillian d. PLoS One. 2018 Nov 28;13(11):e0206595. doi: 10.1371/journal.pone.0206595. eCollection 2018. PLoS One. 2018. PMID: 30485311 Free PMC article.
Long-term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of Inflammation.
Tozay S, Fischer WA, Wohl DA, Kilpatrick K, Zou F, Reeves E, Pewu K, DeMarco J, Loftis AJ, King K, Grant D, Schieffelin J, Gorvego G, Johnson H, Conneh T, Williams G, Nelson JAE, Hoover D, McMillian D, Merenbloom C, Hawks D, Dube K, Brown J. Tozay S, et al. Among authors: mcmillian d. Clin Infect Dis. 2020 Oct 23;71(7):1749-1755. doi: 10.1093/cid/ciz1062. Clin Infect Dis. 2020. PMID: 31693114 Free PMC article.
The impact of semen testing for Ebola virus RNA on sexual behavior of male Ebola survivors in Liberia.
Tompkins K, Brown J, Tozay S, Reeves E, Pewu K, Johnson H, Williams G, Conneh T, Diggs J, DeMarco J, King K, McMillian D, Merenbloom C, Fischer W, Wohl DA. Tompkins K, et al. Among authors: mcmillian d. PLoS Negl Trop Dis. 2020 Sep 14;14(9):e0008556. doi: 10.1371/journal.pntd.0008556. eCollection 2020 Sep. PLoS Negl Trop Dis. 2020. PMID: 32925964 Free PMC article.
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.
Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Liu E, et al. Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24. Neurology. 2015. PMID: 26208959 Free PMC article. Clinical Trial.
18 results